What does MEDI-CL do?

MEDI-CL is a specialist medical practice in Gesves. Private Limited, started on 26 February 2021, 1 establishment.

What is the address of MEDI-CL?

The registered office of MEDI-CL is located at Rue de Sierpont 29, 5340 Gesves.

Is MEDI-CL still active?

Yes. According to the CBE (30 October 2026) MEDI-CL is active, legal situation “Normale toestand”, started on 26 February 2021.

Is MEDI-CL registered on Peppol?

Yes, MEDI-CL is registered on the Peppol network with ID 0208:0764406322.

What is the enterprise number of MEDI-CL?

The enterprise number of MEDI-CL is BE0764406322.

When was MEDI-CL founded?

MEDI-CL was founded on 26 February 2021.

Who are the directors of MEDI-CL?

According to the 2025 annual accounts, the directors of MEDI-CL are: Charlotte Lepère.

Is MEDI-CL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 February 2021; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MEDI-CL make in 2025?

MEDI-CL posted a profit after taxes of € 34,564 in financial year 2025.

What is the revenue of MEDI-CL?

As a small company, MEDI-CL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 53,591.

MEDI-CL (Private Limited) - Gesves - BE0764406322

Dossier MEDI-CL, printed on 30 October 2026 from databakkes.be/en/0764406322/medi-cl. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

MEDI-CL from Gesves, company number BE0764406322, closed financial year 2025 with a result of € 34,564 after tax. For that financial year MEDI-CL recorded a gross margin of € 53,591 and equity of € 28,214. Compared with financial year 2024, the result moved from € 14,102 to € 34,564. Profitable, and profit is growing. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on April 20, 2026.

What it is worth Healthy

€ 28,214

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 34,564

▲ 145% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 47,205

▼ 38% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 34,564 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 1,209

▼ 83% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 11 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 38,296

▲ € 36,463 vs 2024

€ 3,494 is repaid this year. At this pace the long-term loan is gone in ≈ 11 years.

Taxes

€ 10,422

▲ 83% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 80,836 Gross margin 2022: € 80,836 First fiscal year in the series	€ 72,739 Gross margin 2023: € 72,739 ▼ 10% vs 2022 (€ 80,836) Unfavourable step	€ 26,421 Gross margin 2024: € 26,421 ▼ 64% vs 2023 (€ 72,739) Unfavourable step	€ 53,591 Gross margin 2025: € 53,591 ▲ 103% vs 2024 (€ 26,421) Favourable step	▲ 103%
Profit after taxes	€ 57,332 Profit after taxes 2022: € 57,332 First fiscal year in the series	€ 51,404 Profit after taxes 2023: € 51,404 ▼ 10% vs 2022 (€ 57,332) Unfavourable step	€ 14,102 Profit after taxes 2024: € 14,102 ▼ 73% vs 2023 (€ 51,404) Unfavourable step	€ 34,564 Profit after taxes 2025: € 34,564 ▲ 145% vs 2024 (€ 14,102) Favourable step	▲ 145%
Equity	€ 28,214 Equity 2022: € 28,214 First fiscal year in the series	€ 79,618 Equity 2023: € 79,618 ▲ 182% vs 2022 (€ 28,214) Favourable step	€ 28,214 Equity 2024: € 28,214 ▼ 65% vs 2023 (€ 79,618) Unfavourable step	€ 28,214 Equity 2025: € 28,214 Unchanged (€ 28,214) Unchanged
Total debts	€ 79,496 Total debts 2022: € 79,496 First fiscal year in the series	€ 30,132 Total debts 2023: € 30,132 ▼ 62% vs 2022 (€ 79,496) Favourable step	€ 74,147 Total debts 2024: € 74,147 ▲ 146% vs 2023 (€ 30,132) Unfavourable step	€ 104,929 Total debts 2025: € 104,929 ▲ 42% vs 2024 (€ 74,147) Unfavourable step	▲ 42%
Cash	€ 73,958 Cash 2022: € 73,958 First fiscal year in the series	€ 87,148 Cash 2023: € 87,148 ▲ 18% vs 2022 (€ 73,958) Favourable step	€ 76,565 Cash 2024: € 76,565 ▼ 12% vs 2023 (€ 87,148) Unfavourable step	€ 47,205 Cash 2025: € 47,205 ▼ 38% vs 2024 (€ 76,565) Unfavourable step	▼ 38%
Retained profit	€ 28,114 Retained profit 2022: € 28,114 First fiscal year in the series	€ 79,518 Retained profit 2023: € 79,518 ▲ 183% vs 2022 (€ 28,114) Favourable step	€ 28,114 Retained profit 2024: € 28,114 ▼ 65% vs 2023 (€ 79,518) Unfavourable step	€ 28,114 Retained profit 2025: € 28,114 Unchanged (€ 28,114) Unchanged
Dividend	€ 57,332 Dividend 2022: € 57,332 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 57,332) Unchanged	€ 65,506 Dividend 2024: € 65,506 Unchanged (€ 0) Unchanged	€ 34,564 Dividend 2025: € 34,564 ▼ 47% vs 2024 (€ 65,506) Unchanged	▼ 47%
Bank debt	€ 16,350 Bank debt 2022: € 16,350 First fiscal year in the series	€ 9,124 Bank debt 2023: € 9,124 ▼ 44% vs 2022 (€ 16,350) Favourable step	€ 1,833 Bank debt 2024: € 1,833 ▼ 80% vs 2023 (€ 9,124) Favourable step	€ 38,296 Bank debt 2025: € 38,296 ▲ € 36,463 vs 2024 (€ 1,833) Unfavourable step	▲ € 36,463
Balance sheet total	€ 107,710 Balance sheet total 2022: € 107,710 First fiscal year in the series	€ 109,750 Balance sheet total 2023: € 109,750 ▲ 2% vs 2022 (€ 107,710) Unchanged	€ 102,361 Balance sheet total 2024: € 102,361 ▼ 7% vs 2023 (€ 109,750) Unchanged	€ 133,143 Balance sheet total 2025: € 133,143 ▲ 30% vs 2024 (€ 102,361) Unchanged	▲ 30%

Key figures of MEDI-CL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MEDI-CL?

What happened at MEDI-CL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 20, 2026 New annual accounts for financial year 2025: profit of € 34,564 (▲ 145% vs 2024). Source: NBB ↗
Feb 26, 2021 New establishment in Gesves. KBO
Feb 26, 2021 Start of the company according to the CBE. KBO

In short

From € 57,332 profit in 2022 to € 34,564 profit in 2025.

Paid € 47,507 in corporate taxes since 2022.

Best year ever: 2022, with € 57,332 profit.

Paid out € 157,403 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Charlotte Lepère

MEDI-CL

Behind MEDI-CL is Charlotte Lepère.

Directors

According to the 2025 annual accounts

Charlotte Lepère

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de Sierpont 29

5340 Gesves

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0764.406.322
VAT number: BE 0764.406.322
Registered office: Rue de Sierpont 29, 5340 Gesves
Names & denominations: MEDI-CL
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 26 February 2021
Peppol: Active · Active since 30 Dec 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗